Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Motor Activity 55Breast Neoplasms 29Neoplasms 25Lung Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Colorectal Neoplasms 6Colonic Neoplasms 6Polycystic Ovary Syndrome 5Pancreatic Neoplasms 5Obesity 5Lymphoma 5Fatigue 5Multiple Myeloma 4Lymphoma, Follicular 4Lymphedema 4Esophageal Neoplasms 4Brain Neoplasms 4Stomach Neoplasms 3Prostatic Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Leukemia 3Hematologic Neoplasms 3Skin Neoplasms 2Sarcopenia 2Recurrence 2Rectal Neoplasms 2Peripheral Nervous System Diseases 2Neoplasm Metastasis 2Melanoma 2

Interventions

Vincristine 1Radiotherapy 1Pemetrexed 1HhAntag691 1Gemcitabine 1Exercise 1Cyclophosphamide 1Craniospinal Irradiation 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infratentorial Neoplasms × Exercise × 1 year × Clear all
NCT01878617 2025-11-13

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
660 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Infratentorial Neoplasms, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡